Pulmonary embolism (PE) represents the third leading cause of cardiovascular mortality.
The technological landscape for management of acute intermediate-and high-risk PE is …

Objectives: The aim of this study was to determine the lowest optimal tissue plasminogen
activator (tPA) dose and delivery duration using ultrasound-facilitated catheter-directed …

Objectives This study conducted a prospective, single-arm, multicenter trial to evaluate the
safety and efficacy of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis, using …

Importance Thrombolytic therapy may be beneficial in the treatment of some patients with
pulmonary embolism. To date, no analysis has had adequate statistical power to determine …

BACKGROUND Systemic thrombolysis for acute pulmonary embolism (PE) carries up to a
20% risk of major bleeding, including a 2% to 5% risk of hemorrhagic stroke. We evaluated …

Systemic Thrombolysis for Pulmonary Embolism: A Review - PMC Back to Top Skip to main
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …

Background Few contemporary studies have assessed the management and outcomes of
patients with massive and submassive pulmonary embolism. Given advances in therapy, we …

Purpose To evaluate the feasibility of aspiration thrombectomy in patients with acute
massive or submassive pulmonary embolism (PE). Materials and Methods This prospective …

Objective The purpose of this study was to determine the short-term and midterm outcomes
of catheter-directed intervention (CDI) compared with anticoagulation (AC) alone in patients …

Pulmonary embolism (PE) is a leading cause of cardiovascular mortality worldwide. Clinical
presentation can be diverse, and clinicians should have a high index of suspicion regarding …